Tag: Jeffrey Hochberg
AIM Vaccine taps S&C and Jingtian on HKD156m listing on HKEX
China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX
LATEST ON VANTAGE ASIA
Best-laid plans
The Chinese co-chair of IBA’s antitrust section talks about her ambition to broaden the horizons for the country's lawyers in the competition arena
MOST READ ON VANTAGE ASIA
The big squeeze
Should India tighten its grip over international technology companies, or will this approach backfire and cause them to reconsider growth plans in India?
Mediation by necessity
With litigation increasingly seen as problematic, mediation is emerging as a preferred way to resolve disputes
Best-laid plans
The Chinese co-chair of IBA’s antitrust section talks about her ambition to broaden the horizons for the country's lawyers in the competition arena
